SCHEMBL46316

SCHEMBL46316

Cc1ccc(N2CCC(F)C2=O)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
STAT3 P40763 1/20 0.41
STAT1 P42224 1/20 0.41
RAB9A P51151 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
GRM5 P41594 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
TSHR P16473 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL46307 0.83 GPR119 (0.41) SMN1; SMN2NPC1TP53PKMSTAT3
SCHEMBL411138 0.82 GRIN2D (0.38) NPC1RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL469887 0.82 ROCK2 (0.33) GRM5ROCK2
SCHEMBL6893476 0.74 GPR119 (0.41) SMN1; SMN2NPC1TP53PKMSTAT3
SCHEMBL38109 0.73
SCHEMBL46339 0.72 GRIN2D (0.46) SMN1; SMN2NPC1TP53PKMSTAT3
SCHEMBL14734000 0.72 GPR119 (0.55) SMN1; SMN2GPR119GRIN2DGRIN3BGRIN1
SCHEMBL16260556 0.70 GPR119 (0.49) GPR119GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16260503 0.70 GPR119 (0.49) GPR119GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL19454936 0.70 TDO2 (0.48) SMN1; SMN2NPC1TP53PKMSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011151436-A2 NOVEL COMPOUNDS, METHOD FOR USE THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM EUROSCREEN S.A. (BE) 2011-12-08 WO disclosed